Published in Ugeskr Laeger on September 05, 1977
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry (1983) 6.38
Mycoplasma genitalium: a cause of male urethritis? Genitourin Med (1993) 3.02
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry (1983) 2.32
Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis (1998) 1.72
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56
[Effect of a safe-sex campaign on women attending a clinic of venereology. Sex behavior and prevalence of sexually transmitted diseases in women examined at the Venereaklinik in Copenhagen in 1984 and 1988]. Ugeskr Laeger (1993) 1.38
Long-term storage of samples for flow cytometric DNA analysis. Cytometry (1983) 1.36
Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis (2000) 1.29
Sexual behaviour of women attending an inner-city STD clinic before and after a general campaign for safer sex in Denmark. Genitourin Med (1992) 1.22
Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis. Cancer Res (1982) 1.18
Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet (1987) 1.15
In vitro comparison and evaluation of seven gastric closure modalities for natural orifice transluminal endoscopic surgery (NOTES). Endoscopy (2008) 1.08
Seroreactivity to human papillomavirus type 16 virus-like particles is lower in high-risk men than in high-risk women. J Infect Dis (1997) 1.08
Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group. Genitourin Med (1997) 1.08
Erythromycin for four or seven days against Chlamydia trachomatis. Genitourin Med (1985) 1.07
[Occurrence of antibody to human T-cell leukemia/lymphovirus type III (LAV/HTLV III) in venereology clientele in Copenhagen]. Ugeskr Laeger (1986) 1.06
Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. Cancer Res (1980) 1.05
Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia. Acta Pathol Microbiol Scand A (1973) 1.02
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer (1983) 1.02
Membrane transport of anthracyclines. Pharmacol Ther (1982) 1.00
Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med (1988) 0.99
Interstitial fluid: exchange of macromolecules between plasma and skin interstitium. Clin Physiol (1981) 0.98
Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer (1998) 0.98
Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. Eur J Haematol (1989) 0.98
Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF. Eur J Clin Invest (1992) 0.98
Erythromycin against Chlamydia trachomatis infections. A double blind study comparing 4- and 7-day treatment in men and women. Dan Med Bull (1985) 0.95
Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer (1981) 0.94
Mechanism of resistance to anthracyclines and vinca alkaloids. Prog Clin Biol Res (1983) 0.93
Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: results of CALGB protocol 7113. Leuk Res (1979) 0.91
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. Cancer (1988) 0.91
Risk factors for hepatitis B virus infection in heterosexuals attending a venereal disease clinic in Copenhagen. Scand J Infect Dis (1993) 0.89
Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with Treosulfan (= dihydroxybusulfan). Cancer (1980) 0.89
Partner notification in HIV-1 infection: a population based evaluation of process and outcomes in Scotland. Sex Transm Infect (2001) 0.89
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principle. Cancer Treat Rev (1984) 0.89
[Knowledge, attitude and behavior among patients with Chlamydia. Perspectives for prevention]. Ugeskr Laeger (1997) 0.89
Chlamydia trachomatis sampling during erythromycin treatment. Dan Med Bull (1984) 0.88
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells. Cancer Chemother Pharmacol (1987) 0.88
Risk behaviours for HIV infection and sexually transmitted diseases among female sex workers from Copenhagen. Int J STD AIDS (1995) 0.88
Persistant oedema in allergic contact dermatitis. Contact Dermatitis (1983) 0.87
Synchronization of the human promyelocytic cell line HL 60 by thymidine. Cell Tissue Kinet (1986) 0.87
Meningeal involvement in non-Hodgkin's lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol (1985) 0.86
Psoriatic arthritis treated with oral zinc sulphate. Br J Dermatol (1980) 0.86
Capillary microscopy of the nailfold in psoriatic and rheumatoid arthritis. Scand J Rheumatol (1981) 0.85
PHASE I clinical trial of an oral solution of VP-16-213. Cancer Treat Rep (1976) 0.84
Microvascular protein leakage in extensive skin diseases: aspects of the transport mechanisms. J Invest Dermatol (1980) 0.84
Transvascular transport and distribution of fluid and protein in psoriasis. J Am Acad Dermatol (1983) 0.84
Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection (1993) 0.83
Thyroid function in malignant lymphoma. Acta Med Scand (1977) 0.83
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma. J Am Acad Dermatol (1986) 0.83
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease. Cancer Treat Rep (1982) 0.83
Comparison of cyclosporin A and SDZ PSC833 as multidrug-resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor. Cancer Chemother Pharmacol (1992) 0.83
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumors. Cancer Chemother Rep (1972) 0.83
[Hepatitis B in a venereological clientele in Copenhagen]. Ugeskr Laeger (1984) 0.83
Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor. Eur J Haematol (1993) 0.82
Distribution and degradation of albumin in extensive skin disease. Br J Dermatol (1981) 0.82
Patterns and trends of sexual behavior, HIV testing, and HIV prevalence among all sexually transmitted disease clinic attenders in Denmark. Sex Transm Dis (1997) 0.82
Fatal hepatitis following irradiation and vincristine. Acta Med Scand (1982) 0.82
A phase I/II study of dose and administration of non-glycosylated bacterially synthesized G-M CSF in chemotherapy-induced neutropenia in patients with non-Hodgkin's lymphomas. Leuk Lymphoma (1992) 0.81
The epipodophyllotoxin derivatives VM-26 and VP-16-213, 1976-1979, a review. Recent Results Cancer Res (1980) 0.81
Effect of age on therapeutic response and survival in advanced Hodgkin's disease. Cancer Treat Rep (1982) 0.81
Transmission of chlamydial infections to sexual partners. Genitourin Med (1987) 0.81
Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep (1972) 0.81
Activation of complement in the skin after PUVA therapy. Acta Derm Venereol (1984) 0.81
Nuclear imaging of pulmonary metastases in thyroid carcinoma. Acta Radiol Oncol (1980) 0.81
Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies. Cancer Treat Rep (1982) 0.80
Anticoagulant treatment of acute coronary thrombosis. Acta Med Scand (1969) 0.80
Direct and indirect effects of UVA on skin vessel leakiness. J Invest Dermatol (1982) 0.80
Microvascular leakage of plasma proteins after short-term PUVA treatment. J Invest Dermatol (1980) 0.80
Microvascular leakage of plasma proteins after PUVA and UVA. J Invest Dermatol (1982) 0.80
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemia. Br J Haematol (1980) 0.80
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B. J Clin Oncol (1986) 0.80
Immunohistochemical identification of lymphocyte subsets and accessory cells in human hyperplastic lymph nodes. The functional significance of the compartmentalization of lymphoid tissue. Scand J Haematol (1984) 0.80
[Diagnosis and therapeutic control of gonorrhea. Effects and costs]. Ugeskr Laeger (1986) 0.79
Prognostic factors in Hodgkin's disease stage IV. Eur J Haematol (1988) 0.79
Daunorubicin in the therapy of acute granulocytic leukemia. Cancer Res (1973) 0.79
Prognostic significance of tumour burden in Hodgkin's disease PS I and II. Scand J Haematol (1986) 0.79
Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent. Cancer Chemother Rep (1972) 0.79
Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells. Br J Cancer (1993) 0.78
Changes over the course of time in histological subclassification of Hodgkin's disease in Denmark. Dan Med Bull (1991) 0.78
Clinical experience with bacteraemia in patients with leukaemia and allied neoplastic diseases. Chemotherapy (1978) 0.78
Transcapillary escape rate of albumin and plasma volume in patients with varying degrees of psoriasis. Br J Dermatol (1977) 0.78
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Cancer Treat Rep (1984) 0.78
Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B. Cancer (1993) 0.78
Anthracycline resistance. Acta Oncol (1989) 0.78
Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy. Acta Med Scand (1983) 0.78
Modulation of neutrophil and monocyte function by recombinant human granulocyte macrophage colony-stimulating factor in patients with lymphoma. Eur J Clin Invest (1991) 0.77
Lymphatic albumin clearance from psoriatic skin. J Am Acad Dermatol (1983) 0.77
A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria. Cancer (1989) 0.77
In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analogues. Biochem Pharmacol (1990) 0.77
Phase I trial of a new form of an oral administration of VP-16-213. Cancer Treat Rep (1979) 0.77
In vivo kinetics of 111indium-labelled autologous granulocytes following i.v. administration of granulocyte-macrophage colony-stimulating factor (GM-CSF). Eur J Haematol (1992) 0.77